TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
Go back to TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS| Amgen Inc (NASDAQ: AMGN) | Delayed: 396.81 -40.42 (9.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $437.23 | 52 Week High | $176.85 | |||
| Open | $408.90 | 52 Week Low | $133.64 | |||
| Day High | $410.03 | P/E | 59.76 | |||
| Day Low | $392.00 | EPS | $6.64 | |||
| Volume | 3,308,508 | |||||
